ホルモン療法の世界市場レポート 2024年

ホルモン療法市場規模は近年力強く成長しています。2023年の181億8,000万米ドルから2024年には191億3,000万米ドルへと、CAGR7.3％で拡大します。この期間に見られた成長は、医療技術の進歩、女性の健康革命、意識の高まりと教育、継続的な臨床研究開発、ヘルスケアの進化など、いくつかの要因によるものです。

ホルモン療法市場の成長には、ホルモンバランスの乱れの急増が大きく寄与しています。ホルモンバランスの乱れは、体内のホルモン産生量が過剰または不足することで発生し、甲状腺機能低下症、性腺機能低下症、成長ホルモン欠乏症などの様々な疾患を引き起こします。これらの障害に対処するために、エストロゲン補充、テストステロン補充、インスリン療法などのホルモン療法が採用されています。ロンドン・メディカル・ラボラトリーによる2022年の報告書では、2年前と比較して著しいホルモンバランスの乱れが19％増加すると予測されています。その結果、ホルモンバランスの乱れの有病率の上昇は、ホルモン療法市場を促進すると予想されます。

ホルモン療法市場の成長は、高齢者の増加によってさらに促進されます。後期高齢者の代表である高齢者人口は、しばしば加齢に関連した健康問題を抱えます。ホルモン治療は、ホルモンバランスの乱れを修正し、加齢に関連する病気を管理する上で重要な役割を果たしています。2022年11月のAmerica's Health Rankingsによると、米国では65歳以上の高齢者が5,580万人を超え、総人口の約16.8％を占めると予測されています。したがって、高齢者人口の拡大がホルモン療法市場の成長に寄与する重要な要因となっています。

2023年のホルモン療法市場で最大の地域は北米でした。ホルモン療法市場レポートに掲載されている地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 ホルモン療法市場の特徴

第3章 ホルモン療法市場の動向と戦略

第4章 ホルモン療法市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のホルモン療法市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 ホルモン療法市場セグメンテーション

• 世界のホルモン療法市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• エストロゲンホルモン補充
• 成長ホルモン補充
• 甲状腺ホルモン補充
• テストステロン補充
• 世界のホルモン療法市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• その他
• 世界のホルモン療法市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 閉経
• 甲状腺機能低下症
• 成長ホルモン欠乏症
• その他
• 世界のホルモン療法市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局と店舗
• オンライン薬局

第7章 ホルモン療法市場の地域および国分析

• 世界のホルモン療法市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のホルモン療法市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋のホルモン療法市場

第9章 中国のホルモン療法市場

第10章 インドのホルモン療法市場

第11章 日本のホルモン療法市場

第12章 オーストラリアのホルモン療法市場

第13章 インドネシアのホルモン療法市場

第14章 韓国のホルモン療法市場

第15章 西欧のホルモン療法市場

第16章 英国のホルモン療法市場

第17章 ドイツのホルモン療法市場

第18章 フランスのホルモン療法市場

第19章 イタリアのホルモン療法市場

第20章 スペインのホルモン療法市場

第21章 東欧のホルモン療法市場

第22章 ロシアのホルモン療法市場

第23章 北米ホルモン療法市場

第24章 米国のホルモン療法市場

第25章 カナダのホルモン療法市場

第26章 南米ホルモン療法市場

第27章 ブラジルのホルモン療法市場

第28章 中東のホルモン療法市場

第29章 アフリカのホルモン療法市場

第30章 ホルモン療法市場の競合情勢と企業プロファイル

• ホルモン療法市場の競合情勢
• ホルモン療法市場の企業プロファイル
  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • Merck KGaA

第31章 世界のホルモン療法市場の競合ベンチマーキング

第32章 世界のホルモン療法市場の競争ダッシュボード

第33章 ホルモン療法市場における主要な合併と買収

第34章 ホルモン療法市場の将来展望と可能性分析

第35章 付録

“Hormone Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormone therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormone therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hormone therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Therapy: Estrogen Hormone Replacement; Growth Hormone Replacement; Thyroid Hormone Replacement; Testosterone Replacement
• 2) By Route of Administration: Oral; Parenteral; Other Routes of Administration
• 3) By Indication: Menopause; Hypothyroidism; Growth Hormone Deficiency; Other Indications
• 4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies And Stores; Online Pharmacies
• Companies Mentioned: Abbott Laboratories; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hormone therapy is a form of treatment aimed at modifying, suppressing, or increasing specific hormones within the body. This therapeutic approach is employed to address hormonal imbalances, such as hypothyroidism and other related conditions.

Key categories of hormone therapy include estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy involves the administration of estrogen to elevate the body's estrogen levels. This treatment is delivered through various routes, including oral and parenteral methods. It finds application in conditions such as menopause, hypothyroidism, and growth hormone deficiency. Distribution channels for hormone therapy encompass hospital pharmacies, retail pharmacies, and online pharmacies.

The hormone therapy market research report is one of a series of new reports from The Business Research Company that provides hormone therapy market statistics, including hormone therapy industry global market size, regional shares, competitors with a hormone therapy market share, detailed hormone therapy market segments, market trends and opportunities, and any further data you may need to thrive in the hormone therapy industry. This hormone therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormone therapy market size has grown strongly in recent years. It will grow from $18.18 billion in 2023 to $19.13 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed during the historical period can be attributed to several factors, including advancements in medical technology, the women's health revolution, heightened awareness and education, ongoing clinical research and development, and the evolution of healthcare practices.

The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $26.49 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be linked to the adoption of a personalized medicine approach, the dynamics of an aging population, a shift in women's health strategies, an increased emphasis on wellness and longevity, and adaptations in regulatory frameworks. Key trends expected during the forecast period include alterations in regulations and guidelines, the impact of changing lifestyles and stress on health, ongoing research and development efforts, and a growing focus on expanding awareness and education in healthcare.

The growth of the hormone therapy market is significantly fueled by a surge in the incidences of hormone imbalance disorders. Hormone imbalance occurs when the body produces an excess or insufficient amount of a hormone, leading to various disorders such as hypothyroidism, hypogonadism, and growth hormone deficiency. Hormone therapies, including estrogen replacement, testosterone replacement, and insulin therapy, are employed to address these disorders. A 2022 report by London Medical Laboratory revealed an anticipated 19% increase in significant hormone imbalances compared to two years prior. Consequently, the rising prevalence of hormone imbalance disorders is expected to propel the hormone therapy market.

The growth of the hormone therapy market is further driven by the increasing number of elderly individuals. The elderly population, representing those in the later stages of life, is often associated with age-related health issues. Hormone treatment plays a crucial role in correcting hormonal imbalances and managing ailments related to aging. According to America's Health Rankings in November 2022, over 55.8 million individuals aged 65 and above were projected to be living in the United States, constituting approximately 16.8% of the total population. Hence, the expanding elderly population is a key factor contributing to the growth of the hormone therapy market.

A notable trend in the hormone therapy market is the emphasis on product innovation. Major companies in the market are focused on introducing innovative treatments for hormone imbalance disorders, aiming to minimize side effects and address additional symptoms. For example, in May 2021, Myovant Sciences and Pfizer received FDA approval for MYFEMBREE, a once-daily medication designed to manage excessive monthly bleeding in premenopausal women with uterine fibroids. This innovation provides significant symptom relief with just one daily pill, and the MYFEMBREE Support Program offers various services for eligible patients.

Companies in the hormone therapy market are adopting a strategic partnership approach to expand their reach, particularly in North African and Middle Eastern countries. This approach involves leveraging mutual strengths and resources for mutual benefits and success. In October 2023, Cosmo Pharmaceuticals announced a strategic agreement with Hikma Pharmaceuticals, granting Hikma exclusive rights to register and market Winlevi in 17 Middle Eastern and North African countries. The agreement includes an initial payment of USD 750,000 to Cassiopeia, a Cosmo subsidiary, and future regulatory and commercial milestones. Hikma will be the exclusive provider of the product, with pricing based on net sales.

In July 2022, Grunenthal Group, a German pharmaceutical company, acquired the testosterone treatment Nebido from Bayer AG for approximately $547.4 million. This strategic move is part of Grunenthal's ongoing acquisition strategy, which includes global rights to Qutenza, rights to ex-Japanese company Zomig, global rights to ex-US company Vimovo, and European rights to Crestor and Nexium. Bayer AG, a German pharmaceutical company specializing in hormone therapy and treatments, was the seller in this acquisition.

Major companies operating in the hormone therapy market report are Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited .

North America was the largest region in the hormone therapy market in 2023. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hormone therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormone therapy market includes revenues earned by entities by providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hormone Therapy Market Characteristics

3. Hormone Therapy Market Trends And Strategies

4. Hormone Therapy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Hormone Therapy Market Size and Growth

• 5.1. Global Hormone Therapy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Hormone Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Hormone Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hormone Therapy Market Segmentation

• 6.1. Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Estrogen Hormone Replacement
• Growth Hormone Replacement
• Thyroid Hormone Replacement
• Testosterone Replacement
• 6.2. Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.3. Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Menopause
• Hypothyroidism
• Growth Hormone Deficiency
• Other Indications
• 6.4. Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies And Stores
• Online Pharmacies

7. Hormone Therapy Market Regional And Country Analysis

• 7.1. Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hormone Therapy Market

• 8.1. Asia-Pacific Hormone Therapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hormone Therapy Market

• 9.1. China Hormone Therapy Market Overview
• 9.2. China Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hormone Therapy Market

• 10.1. India Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hormone Therapy Market

• 11.1. Japan Hormone Therapy Market Overview
• 11.2. Japan Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hormone Therapy Market

• 12.1. Australia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hormone Therapy Market

• 13.1. Indonesia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hormone Therapy Market

• 14.1. South Korea Hormone Therapy Market Overview
• 14.2. South Korea Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hormone Therapy Market

• 15.1. Western Europe Hormone Therapy Market Overview
• 15.2. Western Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hormone Therapy Market

• 16.1. UK Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hormone Therapy Market

• 17.1. Germany Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hormone Therapy Market

• 18.1. France Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hormone Therapy Market

• 19.1. Italy Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hormone Therapy Market

• 20.1. Spain Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hormone Therapy Market

• 21.1. Eastern Europe Hormone Therapy Market Overview
• 21.2. Eastern Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hormone Therapy Market

• 22.1. Russia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hormone Therapy Market

• 23.1. North America Hormone Therapy Market Overview
• 23.2. North America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hormone Therapy Market

• 24.1. USA Hormone Therapy Market Overview
• 24.2. USA Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hormone Therapy Market

• 25.1. Canada Hormone Therapy Market Overview
• 25.2. Canada Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hormone Therapy Market

• 26.1. South America Hormone Therapy Market Overview
• 26.2. South America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hormone Therapy Market

• 27.1. Brazil Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hormone Therapy Market

• 28.1. Middle East Hormone Therapy Market Overview
• 28.2. Middle East Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hormone Therapy Market

• 29.1. Africa Hormone Therapy Market Overview
• 29.2. Africa Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hormone Therapy Market Competitive Landscape And Company Profiles

• 30.1. Hormone Therapy Market Competitive Landscape
• 30.2. Hormone Therapy Market Company Profiles
  • 30.2.1. Abbott Laboratories
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eli Lilly and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. F. Hoffmann-La Roche
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Merck KGaA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Hormone Therapy Market Competitive Benchmarking

32. Global Hormone Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hormone Therapy Market

34. Hormone Therapy Market Future Outlook and Potential Analysis

• 34.1 Hormone Therapy Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Hormone Therapy Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Hormone Therapy Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer